AMRN FY 2022 Earnings — Amarin Corporation plc Revenue & Financial Results | Market Cap Arena

AMRNAmarin Corporation plc

$310M

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$369M-36.7% YoY

Gross Profit

$242M65.7% margin

Operating Income

-$106M-28.7% margin

Net Income

-$106M-28.7% margin

EPS (Diluted)

$-5.20

Cash Flow

Operating Cash Flow

-$180M

Free Cash Flow

-$180M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$886M

Total Liabilities

$291M

Stockholders' Equity

$595M

Cash & Equivalents

$218M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$369M	$583M	-36.7%
Gross Profit	$242M	$462M	-47.5%
Operating Income	-$106M	$11M	-1108.1%
Net Income	-$106M	$8M	-1468.9%